Travere Therapeutics to Present at the Barclays Global Healthcare Conference
Rhea-AI Summary
Travere Therapeutics (NASDAQ: TVTX) will present at the Barclays Global Healthcare Conference on March 17, 2022, at 8:30 a.m. ET. A live webcast can be accessed at this link, with an archived replay available for 30 days. Travere is dedicated to helping patients with rare diseases by providing urgent treatment options and collaborating with the rare disease community to develop impactful therapies. For more information, visit travere.com.
Positive
- None.
Negative
- None.
News Market Reaction – TVTX
In the trading session that priced this news, TVTX declined 1.46%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company
management will
present at the Barclays Global Healthcare Conference on Thursday, March 17, 2022 at 8:30 a.m. ET.
A live webcast will be available at https://ir.travere.com/events-presentations and an archived replay will be accessible for up to 30 days.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com
Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate
Communications
888-969-7879
IR@travere.com
